Navigation Links
Claim Filed Against the Company and Nine Other Defendants in the Haifa Magistrates Court
Date:9/2/2007

HAIFA, Israel, Sept. 2 /PRNewswire/ -- Oil Refineries Ltd. (TASE: ORL) (the "Company" or "ORL"), Israel's largest oil refiner, announced today that it has received a claim (the "Claim"), filed with the Haifa District Court by 17 soldiers and fighters in various IDF units, against the Company and nine other defendants. The Claim was filed regarding cancer and other diseases, which the plaintiffs allege they contracted due to their being in the Kishon River during the course of their military service, at different periods, from the 1950s through to the 1990s.

At this preliminary stage it can be noted that the claims, alleged in the Claim, as well as the legal and factual circumstances relating to the Claim as a whole, are similar to previous claims filed by previous groups of soldiers and fighters, as outlined in the Company's financial statements for 2006, as updated in the financial statements as of June 30, 2007. For additional information on this matter please refer to Note 16 B(2) of the Company's financial statements for the year ending December, 31, 2006 and to Note 6(2) of the Company's financial statements for the period ending June 30, 2007.

About Oil Refineries Ltd.

Oil Refineries Ltd. (ORL), located in the bay area of the city of Haifa, is Israel's largest oil refinery. ORL operates sophisticated and state-of- the-art industrial facilities with refining capacity of 9 million tons of crude oil per year, with a Nelson complexity index of 7.4, providing a variety of quality products used in industrial operation, transportation, private consumption, agriculture and infrastructure. The company is also active in the area of Aromatics and Polymers through wholly-owned Gadiv Petrochemical Industries Ltd. and 50% owned Carmel Olefins Ltd. ORL is traded on the Tel Aviv Stock Exchange under the ticker ORL. For additional information please visit the Company's website: http://www.orl.co.il


'/>"/>
SOURCE Oil Refineries Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Ebola Virus - Outbreak Claims More Lives In Uganda.
2. Researchers at Cornell University as been reported using research fund by false claims
3. Health Authorities Claim Some Relief likely from Post floods diseases in Mumbai
4. Encephalitis claims 46 lives in UP
5. Encephalitis Claims 131 lives in Uttar Pradesh
6. Encephalitis Has Claimed 400 Lives In Uttar Pradesh
7. Dengue Claims 15 Lives In West Bengal
8. Palmist Claims to Diagnose Ailments Looking At Your Palm
9. A Blow To Lycopene Supplements Claim To “Health” Fae
10. British Scientists Doubt Delhi Doctor’s Stem Cell Claim
11. ‘Miracle’ HIV Cure Claim Under Scrutin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , ... February 22, 2017 , ... Gevir, a New ... antler velvet, announced its products are coming soon to Amazon.com, the world’s largest online ... Thomson as a means to develop an effective natural treatment for Shelley’s Multiple Sclerosis, ...
(Date:2/22/2017)... CA (PRWEB) , ... February 22, 2017 , ... ... treatment to the thousands of individuals who have recently fallen victim to America’s opioid ... in Orange County, California, where they are free from the shame, stigma, and ...
(Date:2/22/2017)... ... February 22, 2017 , ... The National Academy of Certified ... the April 2017 testing period. NACCM, a nonprofit organization, has provided the premier ... exam is periodically re-calibrated to ensure that newly certified professionals are prepared to ...
(Date:2/22/2017)... ... February 22, 2017 , ... Giving patients with diabetes customized ... room, fewer hospital admissions, and better blood pressure and glycemic control, a ... study can be found here . , The study comes as health ...
(Date:2/22/2017)... ... February 22, 2017 , ... In a 2012 survey, over ... not filling a prescription because they could not afford to pay for it. ... were 30-60%*. At the same time, hospitals, pharmacies, manufacturers and nursing ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017 ... clinical-stage oncology drug development company, announces that it ... Drug Administration (FDA) authorizing the initiation a Phase ... treatment for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) ... (RIT). MabVax plans to initiate the phase I ...
(Date:2/23/2017)... VANCOUVER, British Columbia , Feb. 23, ... ) today announced its year end 2016 financial results.  ... January 2017, OncoGenex, and Achieve Life Science, Inc., a privately ... into a definitive merger agreement under which OncoGenex will ... the proposed merger, Achieve,s stockholders are expected to own ...
(Date:2/23/2017)... 2017 This report analyzes analyzes the worldwide markets for ... comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America ... provided for the period 2015 through 2022. Also, a six-year ... analytics are derived from primary and secondary research. Company profiles ...
Breaking Medicine Technology: